West Pharmaceutical Services (WST) Short-term Investments (2011 - 2013)

West Pharmaceutical Services has reported Short-term Investments for 3 years, with the latest figure at $7.5 million in Q4 2013.

• Quarterly Short-term Investments fell 39.52% year-over-year to $7.5 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $7.5 million (down 39.52% YoY) and the FY2013 annual result came in at $7.5 million, down 39.52% from the prior year.
• Short-term Investments was little changed at $7.5 million in Q4 2013 per WST's latest filing, from $7.5 million in the prior quarter.
• Over five years, Short-term Investments peaked at $26.5 million in Q4 2011 and troughed at -$200000.0 in Q1 2012.
• A 3-year average of $12.6 million and a median of $8.9 million in 2011 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2012 and 2013: Short-term Investments plunged 102.08% in 2012, then jumped 4200.0% in 2013.
• Over 3 years, Short-term Investments stood at $26.5 million in 2011, then plunged by 53.21% to $12.4 million in 2012, then sank by 39.52% to $7.5 million in 2013.
• According to Business Quant data, Short-term Investments over the past three periods registered $7.5 million, $7.5 million, and $7.5 million for Q4 2013, Q3 2013, and Q2 2013 respectively.